<DOC>
	<DOCNO>NCT00015054</DOCNO>
	<brief_summary>The purpose study demonstrate feasibility methylphenidate ( MPD ) effective safe outpatient treatment cocaine-dependent patient comorbid DSM-IV diagnosis Attention Deficit Hyperactivity Disorder ( ADHD ) , demonstrate ability site participate subsequent anticipate controlled trial MPD ( recruitment execution ) , gather preliminary data ability sweat patch detect episode cocaine use .</brief_summary>
	<brief_title>Methylphendidate Treatment Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3</brief_title>
	<detailed_description>Forty-one participant enrol multi-site , outpatient , open-label , ten-week trial . Participants schedule attend three visit per week allow safety efficacy measure take . In addition , participant give two hour individual substance abuse therapy first four week , one hour per week last six week , trial . All participant start total daily dose 20 mg MPD . The total daily dose increase maximum daily dose 60 mg ( 20 mg TID ) maximum dose tolerate participant .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>1 . Subject must 21 50 year age , male female , race . 2 . If female , subject pregnant lactating . 3 . Subject must cocainedependent ( determine SCID clinical interview psychiatrist ) . 4 . Subject must meet DSMIV diagnostic criterion ADHD : 5 . Subject must actively use cocaine , ( BE &gt; 300 ng/ml ) within 30 day screen examination . 6 . Subject must negative cocaine metabolite immediately prior receive study treatment number initial dose MPD , determine first urine test kit result later confirm laboratory urine toxicology ( BE &lt; 300 ng/ml ) . 7 . Subject must willing able give inform consent . 1 . Subject symptom AIDS . 2 . Subject chronic medical disorder require medication . 3 . Subject SCID AxisI psychiatric diagnosis require medication . 4 . Subject meet DSMIV criterion dependence substance except cocaine , alcohol , nicotine , marijuana , caffeine , actively use past two week . 5 . Subject need detoxification alcohol benzodiazepines 6 . Subject take psychotropic medication ( except chloral hydrate insomnia ) . 7 . Subject female childbearing age risk become pregnant use adequate contraceptive technique determine evaluate physician Principal Investigator . 8 . Subject ALT AST level three time laboratory normal 9 . Subject renal function test ( creatinine BUN ) electrolyte level ( K , Na , Cl , HCO3 ) within normal limit baseline . 10 . Subject EKG indicating clinically significant arrhythmia abnormal conduction 11 . Subject organic brain syndrome ( OBS ) evidence psychiatric evaluation . 12 . Subject acute chronic medical psychiatric condition judgment evaluate physician would make study participation difficult unsafe . 13 . Subject enrol another research protocol within past 45 day . 14 . Subject narrow angle glaucoma , history 15 . Subject diagnosis family history Tourettes syndrome 16 . Subject history seizure seizure disorder 17 . Subject adverse reaction methylphenidate 18 . Subject abnormal thyroid function ( determine abnormal T4 level clinically significant ) 19 . Subject treat ADHD psychomotor stimulant within past month . 20 . Subject plan receive psychosocial treatment external designate protocol study participation .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 1999</verification_date>
	<keyword>cocaine dependence</keyword>
</DOC>